Featured

Teva Launches First Generic GLP-1 for Weight Loss: Liraglutide Injection

Teva Pharmaceuticals announced the FDA approval and US launch of its generic version of Saxenda® (liraglutide injection), the first generic glucagon-l...

Home/KnolSights/Regulatory Approvals/Teva Launches First Generic GLP-1 for Weight Loss: Liraglutide Injection